Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

SCR005

Catalog No. T213302 Copy Product Info
🥰Excellent
SCR005 is a synthetic carbohydrate receptor (SCR) with broad-spectrum antiviral activity. It inhibits the entry of enveloped viruses from several families, including Coronaviridae (SARS-CoV-1, SARS-CoV-2, MERS-CoV), Filoviridae (EBOV, MARV), and Paramyxoviridae (NiV, HeV), as well as the glycosylated non-enveloped rotavirus. SCR005 binds to viral envelope N-glycans, blocking the virus from attaching to host cells or disrupting both attachment and membrane fusion. It demonstrates a preventive effect in hACE2 mice infected with SARS-CoV-2. SCR005 is applicable for the study and prevention of enveloped viral pandemics.

SCR005

Copy Product Info
🥰Excellent
Catalog No. T213302

SCR005 is a synthetic carbohydrate receptor (SCR) with broad-spectrum antiviral activity. It inhibits the entry of enveloped viruses from several families, including Coronaviridae (SARS-CoV-1, SARS-CoV-2, MERS-CoV), Filoviridae (EBOV, MARV), and Paramyxoviridae (NiV, HeV), as well as the glycosylated non-enveloped rotavirus. SCR005 binds to viral envelope N-glycans, blocking the virus from attaching to host cells or disrupting both attachment and membrane fusion. It demonstrates a preventive effect in hACE2 mice infected with SARS-CoV-2. SCR005 is applicable for the study and prevention of enveloped viral pandemics.

SCR005
Cas No. 2409183-70-4
Pack SizePriceUSA StockGlobal StockQuantity
10 mgInquiry10-14 weeks10-14 weeks
50 mgInquiry10-14 weeks10-14 weeks
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
SCR005 is a synthetic carbohydrate receptor (SCR) with broad-spectrum antiviral activity. It inhibits the entry of enveloped viruses from several families, including Coronaviridae (SARS-CoV-1, SARS-CoV-2, MERS-CoV), Filoviridae (EBOV, MARV), and Paramyxoviridae (NiV, HeV), as well as the glycosylated non-enveloped rotavirus. SCR005 binds to viral envelope N-glycans, blocking the virus from attaching to host cells or disrupting both attachment and membrane fusion. It demonstrates a preventive effect in hACE2 mice infected with SARS-CoV-2. SCR005 is applicable for the study and prevention of enveloped viral pandemics.
In vitro
SCR005, used at a concentration of 10 μM for 30 minutes, inhibits the infection of pseudotyped virus particles (PVPs) from SARS-CoV-1, SARS-CoV-2, MERS-CoV, NiV, HeV, and EBOV in VERO-TMPRSS2 cells.
In vivo
SCR005, administered intranasally at a dose of 3 mg/kg as a single treatment, enhances the survival rate of hACE2 mice infected with SARS-CoV-2.
Chemical Properties
Molecular Weight578.72
FormulaC36H34N8
Cas No.2409183-70-4
SmilesC(/N=C/C1=CC=CN1)C=2C=C(C=C(C/N=C/C3=CC=CN3)C2)C4=CC(C/N=C/C5=CC=CN5)=CC(C/N=C/C6=CC=CN6)=C4
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Citations

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy SCR005 | purchase SCR005 | SCR005 cost | order SCR005 | SCR005 in vivo | SCR005 in vitro | SCR005 formula | SCR005 molecular weight